You just read:

BeyondSpring's Promising Clinical Data for Lead Asset on Non-Small Cell Lung Cancer Treatment Selected for Presentation at 2017 ASCO-SITC Clinical Immuno-Oncology Symposium

News provided by

BeyondSpring Pharmaceuticals

21 Feb, 2017, 17:00 ET